Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2000, p. 39-42, Vol. 44, No. 1
Department of Microbiology, The Chinese
University of Hong Kong, Prince of Wales Hospital, Shatin, N.T.,
Hong Kong, China
Received 14 May 1999/Returned for modification 11 August
1999/Accepted 14 October 1999
Aminoglycoside acetyltransferase was detected in
Mycobacterium kansasii and M. fortuitum but not
in M. avium-M. intracellulare when they were
screened by a radioassay. Aminoglycoside phosphotransferase and
nucleotidyltransferase activities were absent from all three species tested. Acetyltransferases from both M. kansasii
and M. fortuitum displayed relatively high
Kms, all at the millimolar level, for
substrates including tobramycin, neomycin, and kanamycin A. The
Km of each substrate was well above the
corresponding maximum achievable level in serum. The low affinities of
these enzymes for their substrates suggested that drug modification in
vivo was very unlikely. Among the various substrates tested, no
apparent positive correlation was found between substrate affinity and resistance level. The presence of aminoglycoside-modifying enzymes in
these mycobacterial species was therefore not shown to confer resistance to aminoglycosides.
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Aminoglycoside Resistance in Mycobacterium kansasii,
Mycobacterium avium-M. intracellulare, and
Mycobacterium fortuitum: Are Aminoglycoside-Modifying
Enzymes Responsible?
*
Corresponding author. Mailing address: Department of
Microbiology, The Chinese University of Hong Kong, Prince of Wales
Hospital, Shatin, N.T., Hong Kong, China. Phone: (852)-26322875. Fax:
(852)-26473227. E-mail: chiuychan{at}cuhk.edu.hk.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»